These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intermittent vs maintenance medication in schizophrenia. Two-year results. Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588 [TBL] [Abstract][Full Text] [Related]
6. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial. Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668 [TBL] [Abstract][Full Text] [Related]
7. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies. Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J Schizophr Res; 2002 Jan; 53(1-2):145-59. PubMed ID: 11728846 [TBL] [Abstract][Full Text] [Related]
8. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?]. Hornung WP; Buchkremer G; Redbrake M; Klingberg S Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569 [TBL] [Abstract][Full Text] [Related]
9. Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial. Ciudad A; Olivares JM; Bousoño M; Gómez JC; Alvarez E Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1515-22. PubMed ID: 16820255 [TBL] [Abstract][Full Text] [Related]
10. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445 [TBL] [Abstract][Full Text] [Related]
11. Treating prodromal episodes to prevent relapse in schizophrenia. Herz MI; Glazer W; Mirza M; Mostert M; Hafez H Br J Psychiatry Suppl; 1989 Jul; (5):123-7. PubMed ID: 2574984 [No Abstract] [Full Text] [Related]
12. Antipsychotic drug doses in a schizophrenia inpatient unit. Galletly CA Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses]. Chabannes JP; Pelissolo A; Farah S; Gerard D Encephale; 1998; 24(4):386-92. PubMed ID: 9809244 [TBL] [Abstract][Full Text] [Related]
14. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics. De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744 [TBL] [Abstract][Full Text] [Related]
15. Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study. Takeuchi H; Uchida H; Suzuki T; Watanabe K; Kashima H J Clin Psychopharmacol; 2009 Aug; 29(4):394-5. PubMed ID: 19593185 [No Abstract] [Full Text] [Related]
16. Substance abuse and the management of medication nonadherence in schizophrenia. Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865 [TBL] [Abstract][Full Text] [Related]
17. Assessing efficacy of chronic therapy when disease is characterized by frequent relapses: the example of schizophrenia. Morabia A; Ten Have T; Huguelet P; Ferrero F J Clin Epidemiol; 2002 Apr; 55(4):350-7. PubMed ID: 11927202 [TBL] [Abstract][Full Text] [Related]
18. Effects of stringent criteria on eligibility for clozapine among public mental health clients. Juarez-Reyes MG; Shumway M; Battle C; Bacchetti P; Hansen MS; Hargreaves WA Psychiatr Serv; 1995 Aug; 46(8):801-6. PubMed ID: 7583481 [TBL] [Abstract][Full Text] [Related]